Physician profile
Michael J Smith
NPI 1952578940
$2,375.94
in general payments reported to CMS, 2019-2025
11 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.19 · 2022: $389 · 2023: $350 · 2024: $269 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.55 |
| Travel and Lodging | $846.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $910.49 | 2025 | Virtuosaph Plus With Radial Indication |
| Atricure, INC. | $361.73 | 2022-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Abbott Laboratories | $244.16 | 2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Davol INC. | $238.27 | 2023 | Progel Applicator Spray Tips, Arista Ah Flexitip, Channel Drain |
| Medtronic, INC. | $175.66 | 2025 | Penditure |
| Medical Device Business Services, INC. | $137.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $126.18 | 2021-2023 | Xarelto |
| Edwards Lifesciences Corporation | $94.99 | 2022-2025 | Evoque |
| Abiomed | $47.05 | 2024-2025 | Impella |
| La Jolla Pharmaceutical Company | $20.23 | 2023 | Giapreza |
| Chiesi USA, INC. | $20.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.